Megestrol Acetate Suspension
Product Images NDC 0116-4011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 0116-4011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xttrium Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Megestrol Acetate (Megestrol Acetate 8 Oz Bottle)

Megestrol Acetate (Megestrol Acetate 8 Oz Bottle)
This text contains information about a megestrol acetate oral suspension product. The usual dosage, storage instructions, manufacturer details, and other important information are provided. The suspension is lemon-lime flavored, containing 40 mg of micronized megestrol acetate per mL with a maximum alcohol content of 0.34% V/v. It is advised to shake well before dosing and to store in a tight, light-resistant container away from heat. The product is manufactured by Xttrium Laboratories, Inc. If the tamper-evident seal is broken or missing, it should not be used.*
FDA Label Image

Megestrol Acetate Lid (Megestrol Acetate Lid Upload)

Megestrol Acetate Lid (Megestrol Acetate Lid Upload)
This is a description for a unit dose of Megestrol Acetate Oral Suspension USP, containing 400 mg per 10 mL. The product is identified by the National Drug Code (NDC) 0116-4011-10 and is manufactured by Xttrium Laboratories, Inc. It is recommended to shake well before dosing. This medication is for prescription use only.*
FDA Label Image

1 Pint Bottle Label (Screenshot 2025 03 28 132404)

1 Pint Bottle Label (Screenshot 2025 03 28 132404)
This text is a label for Megestrol Acetate Oral Suspension, containing 40 mg/mL of the active ingredient in a lemon-lime flavored oral suspension. It provides instructions on storage conditions, dosage, and manufacturer details. The medication should be kept in a controlled room temperature environment and protected from heat. The seal must be intact before use, and it is recommended to shake well before dosing. The product is dispensed in a light-resistant container with a child-resistant closure.*
FDA Label Image

Megestrol-01 (A697441b Aafb 4be7 Bc29 B16071fed1cf 01)

Megestrol-01 (A697441b Aafb 4be7 Bc29 B16071fed1cf 01)
Megalace tablets contain the active ingredient megestrol acetate, USP. This medication is commonly used to treat conditions like loss of appetite and weight loss in patients with cancer or HIV/AIDS. It acts as an appetite stimulant to help patients regain lost weight and improve overall quality of life.*
FDA Label Image

Megestrol-02 (A697441b Aafb 4be7 Bc29 B16071fed1cf 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.